Commercial development opportunities for Pharma, Biotech and Investors
Chris Mason | Director Regenerative Medicine Bioprocessing Unit UCL
Prof. Chris Mason MBBS, PhD, FSB, FRCSI, FRCS
Stem Cell & Regenerative Medicine Bioprocessing Unit
Advanced Centre for Biochemical Engineering
University College London
Mason is internationally recognized to be at the forefront of the emerging field of cell therapy translation and commercialization. He has a diverse background in academia, surgery and commerce including; former IT entrepreneur and company directorships, a clinical sciences degree (Imperial College), a medical degree (St. Thomas’s Hospital), a PhD in tissue engineering (UCL) and a Fellow of the Royal College of Surgeons. Current responsibilities include; Chair, BIA Cell Therapy Industry Group; Senior Editor, "Regenerative Medicine"; Director, London Regenerative Medicine Network; Trustee, UK Stem Cell Foundation; member of the Biologicals & Vaccines Expert Advisory Group of the Commission on Human Medicines and member of the US Pharmacopeia Monographs - Biologics & Biotechnology Expert Committee. Mason also has a broad range of expertise in commercial consultancy including currently being on the Advisory Boards of several life sciences industry companies based in Europe and North America.
Share this
Appearances at this years' conference:
DAY ONE – Plenary - Monday 21st May 2012
@ 09.00
Chairman’s opening remarks
› Chris Mason, Director Regenerative Medicine Bioprocessing Unit, UCL
DAY ONE - Stream A: Cell Therapy & Regenerative Medicine
@ 14.30
Chairman’s opening remarks
› Chris Mason, Director Regenerative Medicine Bioprocessing Unit, UCL
DAY THREE - Plenary Session - Wednesday 23rd May 2012
@ 13.50
Chairman’s opening remarks
› Chris Mason, Director Regenerative Medicine Bioprocessing Unit, UCL